Fulgent Genetics FLGT Ratios (2015-2026)

NASDAQ FLGT
$20.10 +0.29 (+1.46%)
At close: Oct 19, 2026 · 4:00 PM EDT
Reported Financials

Fulgent Genetics Quarterly Ratios

Periods 45 quarters
Latest Jun 2026

Fulgent Genetics reported a gross margin of 30.07% and a net margin of -34.58% for the quarter ended Jun 2026. These financial ratios cover 45 quarters of results from Mar 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Mar2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
80.92%75.31%75.73%52.08%43.63%19.18%28.43%30.32%47.05%35.78%34.28%37.30%37.32%41.79%38.59%42.10%42.24%39.10%30.21%30.07%
EBT Margin
70.11%59.93%63.07%10.97%1.66%-49.42%-31.81%-21.66%8.10%-205.94%-21.98%-15.79%-25.83%-10.56%-15.96%-26.31%-8.93%-35.13%-36.52%-34.77%
EBIT Margin
69.90%59.94%63.05%10.21%0.33%-53.99%-37.52%-29.18%0.25%-214.34%-33.80%-26.62%-23.81%-21.17%-26.95%-24.10%-18.26%-43.48%-48.67%-42.25%
EBITDA Margin
71.29%61.33%64.52%16.87%9.63%-39.51%-27.12%-19.88%7.83%-205.07%-23.47%-17.95%-15.55%-13.05%-18.89%-16.70%-11.08%-36.15%-40.23%-33.26%
Operating Margin
69.90%59.94%63.05%10.21%0.33%-53.99%-37.52%-29.18%0.25%-214.34%-33.80%-26.62%-23.81%-21.17%-26.95%-24.10%-18.26%-43.48%-48.67%-42.25%
Net Margin
53.77%41.46%48.08%9.20%1.63%-35.20%-23.18%-16.55%-15.48%-181.76%-20.88%-12.26%-20.42%-7.73%-15.69%-23.17%-7.86%-28.10%-34.90%-34.58%
FCF Margin
65.30%28.25%57.16%6.28%14.52%42.07%-15.02%-3.55%6.28%16.77%4.98%-12.19%-48.85%27.87%-12.45%-45.23%6.02%-99.74%2.66%-32.34%
Efficiency
Inventory AverageInventory Avg.
0.78M
Assets AverageAssets Avg.
1,127.26M1,241.69M1,372.16M1,463.63M1,433.72M1,395.92M1,381.41M1,365.67M1,356.49M1,296.86M1,232.61M1,231.06M1,233.00M1,226.86M1,212.85M1,202.79M1,207.20M1,214.04M1,184.95M1,122.80M
Equity AverageEquity Avg.
982.59M1,105.17M1,239.42M1,311.85M1,296.07M1,275.64M1,269.40M1,266.12M1,262.58M1,197.56M1,129.97M1,127.75M1,131.87M1,132.03M1,125.96M1,117.20M1,118.76M1,118.94M1,078.07M1,022.89M
Invested CapitalInvested Cap.
1,065.51M1,187.16M1,339.65M1,336.83M1,310.68M1,293.89M1,298.13M1,275.49M1,270.62M1,137.43M1,129.55M1,131.75M1,137.80M1,132.06M1,125.20M1,114.07M1,128.32M1,114.42M1,046.11M1,003.58M
Asset Utilization RatioAsset Util.
0.920.800.690.630.560.440.260.230.210.220.230.240.230.230.240.250.260.270.270.29
Leverage & Solvency
Interest Coverage RatioInterest Cover
3.060.00M-87.54-756.240.00M-403.380.00M0.00M-548.210.00M0.00M-611.41
Debt Ratio
0.020.020.020.020.020.020.020.010.010.000.000.000.000.000.000.000.000.000.000.00
Times Interest Earned
3.060.00M-87.54-756.240.00M-403.380.00M0.00M-548.210.00M0.00M-611.41
Valuation
Price to EarningsP/E
4.715.984.114.214.176.11
Price to SalesP/S
2.593.061.991.781.411.422.543.602.802.962.262.042.392.011.772.012.212.531.431.74
Price to BookP/B
2.572.601.441.260.880.690.730.880.640.760.580.530.580.500.460.550.620.730.440.56
Enterprise Value
2,220.81M2,590.43M1,314.42M1,140.97M564.73M353.62M426.97M652.96M338.47M430.30M339.62M278.33M446.95M307.46M192.77M310.62M316.37M475.15M176.77M301.94M
EV to EBIT
2.963.832.152.171.541.98
EV to EBITDA
2.923.772.102.101.441.67
Market Capitalization
2,683.12M3,033.79M1,892.71M1,650.40M1,131.44M876.66M926.98M1,107.83M803.14M857.27M648.61M593.74M663.57M569.63M517.49M608.49M697.30M816.50M458.73M564.61M
Price to FCFP/FCF
4.845.893.984.024.083.7322.2035.1937.44178.7536.1450.77
EV to FCF
4.015.032.762.782.041.5110.2320.7415.7889.7218.9223.80
EV to CFO
3.734.812.662.661.901.397.4611.707.4815.948.057.5840.7214.6020.59207.73
Return Ratios
Return on Sales [ROS]ROS
69.90%59.94%63.05%10.21%0.33%-53.99%-37.52%-29.18%0.25%-214.34%-33.80%-26.62%-23.81%-21.17%-26.95%-24.10%-18.26%-43.48%-48.67%-42.25%
Return on Capital Employed [ROCE]ROCE
76.62%59.48%49.65%39.28%27.49%13.65%-3.71%-6.21%-6.25%-15.98%-16.64%-16.59%-18.02%-6.41%-6.27%-6.43%-6.26%-8.07%-9.67%-11.63%
Return on Invested Capital [ROIC]ROIC
56.32%44.53%35.98%29.10%20.24%10.57%-2.63%-4.67%-6.36%-16.24%-16.98%-16.95%-16.74%-5.49%-5.39%-5.65%-5.73%-7.15%-8.72%-11.03%
Return on Assets [ROA]ROA
50.46%40.77%33.46%26.68%18.81%10.17%-1.99%-3.67%-4.79%-13.51%-14.05%-13.87%-13.95%-3.57%-3.45%-4.33%-3.66%-5.08%-6.33%-7.61%
Return on Equity [ROE]ROE
57.89%45.81%37.04%29.77%20.81%11.13%-2.17%-3.96%-5.15%-14.63%-15.33%-15.14%-15.19%-3.87%-3.72%-4.66%-3.95%-5.51%-6.96%-8.36%

Fulgent Genetics Ratios API

Pull Fulgent Genetics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=FLGT&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY